Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 70518-4474

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 70518-4474). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (96f45871 7175 49d8 8374 Dfa2978d38c7 01)

Structural Formula (96f45871 7175 49d8 8374 Dfa2978d38c7 01)
Chemical structure of atorvastatin calcium, depicted as a complex molecular diagram including fluorophenyl, phenyl, and hydroxy functional groups, with calcium ions and water molecules indicated as part of the complex.*
FDA Label Image

Figure1 (96f45871 7175 49d8 8374 Dfa2978d38c7 02)

Figure1 (96f45871 7175 49d8 8374 Dfa2978d38c7 02)
A line chart comparing the cumulative incidence percentage over a period of 3.5 years between Atorvastatin and Placebo. The Atorvastatin group shows a consistently lower cumulative incidence than the Placebo group. The chart includes a hazard ratio (HR=0.64) and a p-value (0.0005), indicating statistical data related to the comparison.*
FDA Label Image

Figure2 (96f45871 7175 49d8 8374 Dfa2978d38c7 03)

Figure2 (96f45871 7175 49d8 8374 Dfa2978d38c7 03)
A line graph showing cumulative hazard percentages over approximately 5 years, comparing Placebo and Atorvastatin groups. The x-axis represents time in years to the first primary endpoint, and the y-axis shows cumulative hazard percentage. Atorvastatin shows a lower cumulative hazard than placebo over the follow-up period, with a hazard ratio (HR) of 0.63 (0.48-0.83) and p-value of 0.001.*
FDA Label Image

Figure3 (96f45871 7175 49d8 8374 Dfa2978d38c7 04)

Figure3 (96f45871 7175 49d8 8374 Dfa2978d38c7 04)
A line graph comparing the percentage of subjects experiencing a cardiovascular event over time for Atorvastatin 10 mg and 80 mg doses. The x-axis represents time in years to first major cardiovascular endpoint, and the y-axis shows the percentage of subjects experiencing the event. The graph includes hazard ratio (HR) and p-value statistics for the comparison.*
FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Atorvastatin Calcium 40 mg white oval tablets, film-coated, packaged in a quantity of 90. The label shows the product is repackaged by RemedyRepack Inc., Indiana, PA, with handling and storage instructions included. Manufacturer listed as LifeStar, Mahwah, NJ. NDC 70518-4474.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.